Trade tension and tariffs force multinationals to eye China-centric supply chains
With the US-China tariff war showing every sign of worsening, multinational firms are considering building ...
© Jiri Hojda
BBC reports:
Denmark has temporarily halted use of the Oxford-AstraZeneca vaccine as a precaution, after reports of a small number of blood clots and one death.
The Danish health authority said it was too early to say whether there was a link to the AstraZeneca vaccine.
Austria earlier stopped using a batch of the drug, prompting the EU medicines agency to say there was no indication the vaccine caused blood clots.
The company says its safety has been studied extensively in clinical trials.
“Patient Safety is the highest priority for AstraZeneca,” a spokesperson said.
To read the full post, please click here.
Now read this: “Covid-19: Several European countries suspend AstraZeneca vaccinations over blood clot fears“.
Comment on this article